Wooyang Co., Ltd. (KOSDAQ:103840)
2,990.00
-60.00 (-1.97%)
At close: May 15, 2026
Wooyang Revenue
In the year 2025, Wooyang had annual revenue of 183.78B KRW with 4.26% growth. Wooyang had revenue of 50.42B in the quarter ending December 31, 2025, with 14.51% growth.
Revenue
183.78B
Revenue Growth
+4.26%
P/S Ratio
0.27
Revenue / Employee
1.77B
Employees
104
Market Cap
49.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 183.78B | 7.52B | 4.26% |
| Dec 31, 2024 | 176.26B | -15.03B | -7.86% |
| Dec 31, 2023 | 191.29B | 27.88B | 17.06% |
| Dec 31, 2022 | 163.41B | 24.24B | 17.42% |
| Dec 31, 2021 | 139.17B | 6.11B | 4.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DAEJIN ADVANCED MATERIALS | 84.51B |
| YounglimwonSoftLab Co.Ltd | 79.88B |
| Formetal | 66.03B |
| RBW Inc. | 46.48B |
| Eagle Veterinary Technology Co.,Ltd | 43.32B |
| WOOJUNG BIO | 37.59B |
| Wonbiogen | 35.24B |
| Aloys | 31.58B |